|
1
|
Chang Q and Wang XL: Effects of chiral
3-n-butylphthalide on apoptosis induced by transient focal cerebral
ischemia in rats. Acta Pharmacol Sin. 24:796–804. 2003.PubMed/NCBI
|
|
2
|
Liu CL, Liao SJ, Zeng JS, Lin JW, Li CX,
Xie LC, Shi XG and Huang RX: dl-3n-butylphthalide prevents stroke
via improvement of cerebral microvessels in RHRSP. J Neurol Sci.
260:106–113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liao SJ, Lin JW, Pei Z, Liu CL, Zeng JS
and Huang RX: Enhanced angiogenesis with dl-3n-butylphthalide
treatment after focal cerebral ischemia in RHRSP. Brain Res.
1289:69–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu J, Wang Y, Li N, Xu L, Yang H and Yang
Z: L-3-n-butylphthalide improves cognitive deficits in rats with
chronic cerebral ischemia. Neuropharmacology. 62:2424–2429. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang L, Yu WH, Wang YX, Wang C, Zhao F,
Qi W, Chan WM, Huang Y, Wai MS, Dong J and Yew DT:
DL-3-n-Butylphthalide, an anti-oxidant agent, prevents neurological
deficits and cerebral injury following stroke per functional
analysis, magnetic resonance imaging and histological assessment.
Curr Neurovasc Res. 9:167–175. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ren J, Sietsma D, Qiu S, Moessler H and
Finklestein SP: Cerebrolysin enhances functional recovery following
focal cerebral infarction in rats. Restor Neurol Neurosci.
25:25–31. 2007.PubMed/NCBI
|
|
7
|
Zhang C, Chopp M, Cui Y, Wang L, Zhang R,
Zhang L, Lu M, Szalad A, Doppler E, Hitzl M and Zhang ZG:
Cerebrolysin enhances neurogenesis in the ischemic brain and
improves functional outcome after stroke. J Neurosci Res.
88:3275–3281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sharma HS, Sharma A, Mössler H and
Muresanu DF: Neuroprotective effects of cerebrolysin, a combination
of different active fragments of neurotrophic factors and peptides
on the whole body hyperthermia-induced neurotoxicity: Modulatory
roles of co-morbidity factors and nanoparticle intoxication. Int
Rev Neurobiol. 102:249–276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sharma HS, Menon PK, Lafuente JV, Aguilar
ZP, Wang YA, Muresanu DF, Mössler H, Patnaik R and Sharma A: The
role of functionalized magnetic iron oxide nanoparticles in the
central nervous system injury and repair: New potentials for
neuroprotection with Cerebrolysin therapy. J Nanosci Nanotechnol.
14:577–595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui LY, Zhu YC, Gao S, Wang JM, Peng B, Ni
J, Zhou LX, He J and Ma XQ: Ninety-day administration of
dl-3-n-butylphthalide for acute ischemic stroke: A randomized,
double-blind trial. Chin Med J (Engl). 126:3405–3410.
2013.PubMed/NCBI
|
|
11
|
Hong Z, Moessler H, Bornstein N, Brainin M
and Heiss WD: CASTA-Investigators: A double-blind,
placebo-controlled, randomized trial to evaluate the safety and
efficacy of Cerebrolysin in patients with acute ischaemic stroke in
Asia - CASTA. Int J Stroke. 4:406–412. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Heiss WD, Brainin M, Bornstein NM,
Tuomilehto J and Hong Z: Cerebrolysin Acute Stroke Treatment in
Asia (CASTA) Investigators: Cerebrolysin in patients with acute
ischemic stroke in Asia: Results of a double-blind,
placebo-controlled randomized trial. Stroke. 43:630–636. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lang W, Stadler CH, Poljakovic Z and Fleet
D: Lyse Study Group: A prospective, randomized, placebo-controlled,
double-blind trial about safety and efficacy of combined treatment
with alteplase (rt-PA) and Cerebrolysin in acute ischaemic
hemispheric stroke. Int J Stroke. 8:95–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cerebrovascular Disease Working Groups,
Chinese Academy of Neurology: Guidelines for the management of
ischemic stroke (China 2010). Zhonghua Shen Jing Ke Za Zhi.
43:146–153. 2010.(In Chinese).
|
|
15
|
Lyden P, Brott T, Tilley B, Welch KM,
Mascha EJ, Levine S, Haley EC, Grotta J and Marler J: Improved
reliability of the NIH stroke scale using video training. NINDS TPA
stroke study group. Stroke. 25:2220–2226. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sulter G, Steen C and De Keyser J: Use of
the Barthel index and modified Rankin scale in acute stroke trials.
Stroke. 30:1538–1541. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guy W: ECDEU assessment manual for
psychopharmacology (revised). U.S. Department of Health, Education,
and Human Welfare Publication No. (ADM) 76–338. Rockville, MD:
341–345. 1976.
|
|
18
|
Liu L, Wang D, Wong KS and Wang Y: Stroke
and stroke care in China: huge burden, significant workload, and a
national priority. Stroke. 42:3651–3654. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu M, Wu B, Wang WZ, Lee LM, Zhang SH and
Kong LZ: Stroke in China: Epidemiology, prevention and management
strategies. Lancet Neurol. 6:456–464. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tymianski M: Novel approaches to
neuroprotection trials in acute ischemic stroke. Stroke.
44:2942–2950. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiong J and Feng YP: The protective effect
of butylphthalide against mitochondrial injury during cerebral
ischemia. Acta Pharmaceutica Sinica. 35:408–412. 2000.
|
|
22
|
Zhang T, Jia W and Sun X:
3-n-Butylphthalide (NBP) reduces apoptosis and enhances vascular
endothelial growth factor (VEGF) up-regulation in diabetic rats.
Neurol Res. 32:390–396. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang T, Yan W, Li Q, Fu J, Liu K, Jia W,
Sun X and Liu X: 3-n-Butylphthalide (NBP) attenuated neuronal
autophagy and amyloid-β expression in diabetic mice subjected to
brain ischemia. Neurol Res. 33:396–404. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang HM, Zhang T, Huang JK and Sun XJ:
3-N-butylphthalide (NBP) attenuates the amyloid-β-induced
inflammatory responses in cultured astrocytes via the nuclear
factor-κB signaling pathway. Cell Physiol Biochem. 32:235–242.
2013. View Article : Google Scholar : PubMed/NCBI
|
